Cusatuzumab (Anti-TNFSF7 / CD27L / CD70)

Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) is a defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). MW: 144.36 kD.
Supplier Selleck Chemicals
Product # A2747
Sku # A2747-1mg
Pricing 1mg, $539.00
Feedback